AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $65,935,050 | +45.0% | 5,400,086 | +23.9% | 0.02% | +33.3% |
Q3 2022 | $45,484,366 | +48.9% | 4,356,740 | +53.1% | 0.01% | +50.0% |
Q2 2022 | $30,554,247 | +30.9% | 2,844,902 | +15.4% | 0.01% | +60.0% |
Q1 2022 | $23,345,046 | -28.7% | 2,465,158 | -13.1% | 0.01% | -28.6% |
Q4 2021 | $32,759,000 | +24.2% | 2,836,238 | +2.7% | 0.01% | +16.7% |
Q3 2021 | $26,384,000 | -29.0% | 2,762,681 | -28.4% | 0.01% | -25.0% |
Q2 2021 | $37,177,000 | +71.9% | 3,856,502 | +76.2% | 0.01% | +60.0% |
Q1 2021 | $21,624,000 | -65.9% | 2,188,692 | -20.3% | 0.01% | -66.7% |
Q4 2020 | $63,431,000 | +21.1% | 2,747,126 | -26.0% | 0.02% | +7.1% |
Q3 2020 | $52,396,000 | -16.2% | 3,710,730 | -10.5% | 0.01% | -22.2% |
Q2 2020 | $62,548,000 | +88.2% | 4,147,749 | +15.3% | 0.02% | +50.0% |
Q1 2020 | $33,241,000 | -0.5% | 3,597,470 | +4.9% | 0.01% | +33.3% |
Q4 2019 | $33,392,000 | +66.3% | 3,428,337 | +37.0% | 0.01% | +50.0% |
Q3 2019 | $20,075,000 | -21.4% | 2,503,099 | +22.4% | 0.01% | -25.0% |
Q2 2019 | $25,525,000 | +20.2% | 2,045,287 | +30.9% | 0.01% | +14.3% |
Q1 2019 | $21,242,000 | +50.2% | 1,561,885 | +5.8% | 0.01% | +40.0% |
Q4 2018 | $14,147,000 | -20.8% | 1,476,707 | 0.0% | 0.01% | -16.7% |
Q3 2018 | $17,854,000 | -22.6% | 1,476,707 | 0.0% | 0.01% | -25.0% |
Q2 2018 | $23,066,000 | +3.9% | 1,476,707 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $22,210,000 | +23.7% | 1,476,707 | +18.3% | 0.01% | +33.3% |
Q4 2017 | $17,958,000 | -4.6% | 1,247,933 | 0.0% | 0.01% | -14.3% |
Q3 2017 | $18,819,000 | +198.9% | 1,247,933 | +99.6% | 0.01% | +250.0% |
Q2 2017 | $6,297,000 | +14.3% | 625,365 | -19.1% | 0.00% | 0.0% |
Q1 2017 | $5,510,000 | +8.8% | 772,857 | -24.1% | 0.00% | 0.0% |
Q4 2016 | $5,064,000 | -29.7% | 1,018,862 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $7,201,000 | +55.0% | 1,018,862 | +19.7% | 0.00% | +50.0% |
Q2 2016 | $4,647,000 | -19.1% | 851,030 | +25.1% | 0.00% | -33.3% |
Q1 2016 | $5,746,000 | -12.9% | 680,030 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $6,596,000 | -39.5% | 680,030 | -12.7% | 0.00% | -50.0% |
Q3 2015 | $10,895,000 | – | 778,747 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 22,790,134 | $182,777,000 | 6.12% |
Perceptive Advisors | 24,609,700 | $197,369,000 | 5.32% |
SECTORAL ASSET MANAGEMENT INC | 3,441,922 | $27,604,000 | 4.76% |
Palo Alto Investors LP | 7,162,920 | $57,447,000 | 3.83% |
Avoro Capital Advisors LLC | 11,100,000 | $89,022,000 | 3.71% |
SPHERA FUNDS MANAGEMENT LTD. | 2,930,320 | $23,501,000 | 3.63% |
Ghost Tree Capital, LLC | 1,705,000 | $13,674,000 | 3.48% |
Novo Holdings A/S | 2,317,870 | $18,589,000 | 3.18% |
Copernicus Capital Management, LLC | 335,000 | $2,687,000 | 2.50% |
Boxer Capital, LLC | 2,325,000 | $18,647,000 | 1.35% |